CELLULAR BIOMEDICINE GROUP, INC. Stock-Based Compensation
CELLULAR BIOMEDICINE GROUP, INC. reported Stock-Based Compensation of $2.70 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-11-09
- CELLULAR BIOMEDICINE GROUP, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-09-30 was $891.01K, a 10.53% decline year-over-year.
- CELLULAR BIOMEDICINE GROUP, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $954.57K.
- CELLULAR BIOMEDICINE GROUP, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $995.88K.
- CELLULAR BIOMEDICINE GROUP, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $4.06M, a 15.80% decline from fiscal 2018.
- CELLULAR BIOMEDICINE GROUP, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $4.83M, a 9.70% decline from fiscal 2017.
- CELLULAR BIOMEDICINE GROUP, INC. share-based payment arrangement, noncash expense for fiscal 2017 was $5.35M, a 1.97% decline from fiscal 2016.
- CELLULAR BIOMEDICINE GROUP, INC. share-based payment arrangement, noncash expense for fiscal 2016 was $5.45M, a 28.19% decline from fiscal 2015.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2020-09-30 | $891.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.70M 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $1.80M 10-Q · filed 2020-08-12 | ||||
| 2019-12-31 | $954.57K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.95M derived: sum of 2 quarters · filed 2020-11-09 | $4.06M 10-K · filed 2020-02-28 | ||
| 2019-09-30 | $995.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.11M 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $2.11M 10-Q · filed 2020-08-12 | ||||
| 2018-12-31 | $4.83M 10-K · filed 2020-02-28 | ||||
| 2017-12-31 | $5.35M 10-K · filed 2020-02-28 | ||||
| 2016-12-31 | $5.45M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | $7.59M 10-K · filed 2018-03-05 | ||||
| 2014-12-31 | $2.53M 10-K · filed 2017-03-13 | $1.95M 10-K · filed 2015-03-31 | |||
| 2013-12-31 | $4.38M 10-K · filed 2016-03-14 | ||||
| 2011-09-30 | $80.59K 10-Q · filed 2011-11-14 | ||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 |